These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 37004060)

  • 1. Integrative analysis of a novel super-enhancer-associated lncRNA prognostic signature and identifying LINC00945 in aggravating glioma progression.
    Yang Z; Zheng Y; Wu H; Xie H; Zhao J; Chen Z; Li L; Yue X; Zhao B; Bian E
    Hum Genomics; 2023 Mar; 17(1):33. PubMed ID: 37004060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma.
    Tao C; Luo H; Chen L; Li J; Zhu X; Huang K
    Bioengineered; 2021 Dec; 12(1):4016-4031. PubMed ID: 34288803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value and immune landscaps of m6A/m5C-related lncRNAs signature in the low grade glioma.
    Li R; Chen H; Li C; Qi Y; Zhao K; Wang J; You C; Huang H
    BMC Bioinformatics; 2023 Jul; 24(1):274. PubMed ID: 37403043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A TGF-β signaling-related lncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response.
    Duan WW; Yang LT; Liu J; Dai ZY; Wang ZY; Zhang H; Zhang X; Liang XS; Luo P; Zhang J; Liu ZQ; Zhang N; Mo HY; Qu CR; Xia ZW; Cheng Q
    CNS Neurosci Ther; 2024 Apr; 30(4):e14489. PubMed ID: 37850692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients.
    He Y; Ye Y; Tian W; Qiu H
    Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662
    [No Abstract]   [Full Text] [Related]  

  • 6. Integrative analysis of multi-omics data reveals a pseudouridine-related lncRNA signature for prediction of glioma prognosis and chemoradiotherapy sensitivity.
    Yang Y; Wang F; Teng H; Zhang C; Zhang Y; Chen P; Li Q; Kan X; Chen Z; Wang Z; Yu Y
    Comput Biol Med; 2023 Nov; 166():107428. PubMed ID: 37748218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of oxidative stress-related lncRNA signatures in glioma reveals the discrepancy of prognostic and immune infiltration.
    Shi Z; Wu Y; Zhuo Q; Zuo Y; Lin J; Shi H; Zhou H; Xu Z
    Sci Rep; 2023 May; 13(1):7731. PubMed ID: 37173373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Prognostic Signature of Necroptosis-Related lncRNAs and Molecular Subtypes in Glioma.
    Zhang G; Chen R; Zhu L; Ma H; Tang H; Shang C; Wang J; Zhang D; Li Q; Liu J
    Comput Math Methods Med; 2022; 2022():3440586. PubMed ID: 36110575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Immune-Related lncRNA Signature to Predict Survival In Glioma Patients.
    Xia P; Li Q; Wu G; Huang Y
    Cell Mol Neurobiol; 2021 Mar; 41(2):365-375. PubMed ID: 32410107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Super-enhancer-associated TMEM44-AS1 aggravated glioma progression by forming a positive feedback loop with Myc.
    Bian E; Chen X; Cheng L; Cheng M; Chen Z; Yue X; Zhang Z; Chen J; Sun L; Huang K; Huang C; Fang Z; Zhao B; Li J
    J Exp Clin Cancer Res; 2021 Oct; 40(1):337. PubMed ID: 34696771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel prognostic related lncRNA signature associated with amino acid metabolism in glioma.
    Lei Q; Yuan B; Liu K; Peng L; Xia Z
    Front Immunol; 2023; 14():1014378. PubMed ID: 37114036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immune-related lncRNA signature for patients with anaplastic gliomas.
    Wang W; Zhao Z; Yang F; Wang H; Wu F; Liang T; Yan X; Li J; Lan Q; Wang J; Zhao J
    J Neurooncol; 2018 Jan; 136(2):263-271. PubMed ID: 29170907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic insights into super-enhancer-driven genes as prognostic signatures in patients with glioblastoma.
    Chen Y; Pan Y; Gao H; Yi Y; Qin S; Ma F; Zhou X; Guan M
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12315-12332. PubMed ID: 37432454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer.
    Zhou M; Lv S; Hou Y; Zhang R; Wang W; Yan Z; Li T; Gan W; Zeng Z; Zhang F; Yang M
    Front Immunol; 2022; 13():994874. PubMed ID: 36330513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling pro-neural to mesenchymal transition identifies a lncRNA signature in glioma.
    Liang Q; Guan G; Li X; Wei C; Wu J; Cheng P; Wu A; Cheng W
    J Transl Med; 2020 Oct; 18(1):378. PubMed ID: 33028341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
    J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analyses indicated the association between m6A related long non-coding RNAs and various pathways in glioma.
    Chen Z; Zhang W; Yan Z; Zhang M
    Cancer Med; 2023 Jan; 12(1):760-788. PubMed ID: 35668574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling hypoxia signaling reveals a lncRNA signature contributing to immunosuppression in high-grade glioma.
    Li X; Xu J; Li X; Shi J; Wei C; Liang Q
    Front Immunol; 2024; 15():1471388. PubMed ID: 39416790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis.
    Zhang C; Liu H; Xu P; Tan Y; Xu Y; Wang L; Liu B; Chen Q; Tian D
    BMC Cancer; 2021 Mar; 21(1):251. PubMed ID: 33750353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel disulfide death-related genes prognostic signature identifies the role of IPO4 in glioma progression.
    Wu H; Yang Z; Chang C; Wang Z; Zhang D; Guo Q; Zhao B
    Cancer Cell Int; 2024 May; 24(1):168. PubMed ID: 38734657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.